SampleCode	Atomic site (Left colon=1, Right colon=2, Rectum=3)	Atomic site	Primary Necrosis	Primary Purity	Metastasis Necrosis	Metastasis Purity	Gender	Age	TNM	Stage	M or noM	Metastatic sites beforein operation	PreTherapy	PreTherapy with targeted agents	Preoperative treatment effect	Postoperative therapy with targeted agents	Hitopathologic type	CEA	CA19.9	Calcium nodus	Intravascular tumor thrombus	Neurological invasion	Invasion in turn	Follow-up time (day)	prognosis (1=Alive, 2=Death, 3=Loss)	Survival	SurvivalTime	Progression	Progression	ProgressionTime	146 cases with proteomephosphoproteome DIA data (480samples)	N_146	P_145	T_146	LM_43	146cases with WES data (330samples)	T_146	LM_38	BC_128	N_18	comment_Paired	
CCRC-0001	1	Desending Colon	10	80	None	None	male	62	T4N0M1	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma	25.67	176.47	0	0	0	0.5	1640	1	Alive	1640	No	No	1640	1	yes	None	yes	yes	1	yes	yes	yes	None	pair_T.BC	
CCRC-0002	3	Rectum	15	70	None	None	male	65	T2N0M1	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma	4.49	8.47	0	0	0	0.5	1293	1	Alive	1293	No	No	1293	2	yes	yes	yes	yes	2	yes	yes	yes	None	pair_T.BC	
CCRC-0005	3	Rectum	5	85	None	None	female	71	T3N0M1	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma	8.85	6.6	1	1	0	1	1333	1	Alive	1333	Yes(liver)	Yes	363	5	yes	yes	yes	yes	5	yes	yes	yes	None	pair_T.BC	
CCRC-0006	2	Asending Colon	20	70	10	80	male	60	T3N2aM1	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma	1.4	3.5	1	0	1	None	984	2	Death	984	Yes(widespread)	Yes	984	6	yes	yes	yes	yes	6	yes	yes	yes	None	pair_T.BC	
CCRC-0007	1	Sigmoid Colon	20	70	None	None	male	72	T3N0M1	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma	14.2	15.3	0	0	0	None	1048	2	Death	1048	Yes(relapse,widespread)	Yes	577	7	yes	yes	yes	yes	7	yes	yes	yes	None	pair_T.BC	
CCRC-0008	3	Rectum	20	70	50	40	male	64	T3N1M1	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma	163.7	>1200	0	0	1	0.75	1498	1	Alive	1498	No	No	1498	8	yes	yes	yes	yes	8	yes	yes	yes	None	pair_T.BC	
CCRC-0010	3	Rectum	10	80	None	None	male	60	T3N0M0	II	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	1.37	3.85	0	0	0	0.5	1413	1	Alive	1413	No	No	1413	10	yes	yes	yes	None	10	yes	None	yes	None	pair_T.BC	
CCRC-0013	2	Asending Colon	20	70	None	None	male	67	T3N0M0	II	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	2.04	14.39	0	None	None	None	1583	1	Alive	1583	No	No	1583	13	yes	yes	yes	None	13	yes	None	yes	None	pair_T.BC	
CCRC-0014	3	Rectum	30	60	None	None	male	65	T3N0M0	II	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	5.47	25.95	0	0	0	0.5	1433	1	Alive	1433	No	No	1433	14	yes	yes	yes	None	14	yes	None	yes	None	pair_T.BC	
CCRC-0015	3	Rectum	5	80	None	None	female	73	T3N0M0	II	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	2.47	4.34	0	0	0	0.33	1237	1	Alive	1237	Yes(unknown)	Yes	1223	15	yes	yes	yes	None	15	yes	None	yes	None	pair_T.BC	
CCRC-0016	2	Asending Colon	5	90	None	None	female	68	T3N0M0	II	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma; Mucinous adenocarcinoma	0.5	4.9	0	None	None	1	1603	1	Alive	1603	No	No	1603	16	yes	yes	yes	None	16	yes	None	yes	None	pair_T.BC	
CCRC-0018	3	Rectum	10	80	None	None	female	58	T3N0M0	II	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	2.08	4.01	0	None	None	0.75	1546	1	Alive	1546	No	No	1546	18	yes	yes	yes	None	18	yes	None	yes	None	pair_T.BC	
CCRC-0019	3	Rectosigmoid Junction	10	85	None	None	male	67	T3N0M0	II	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	5.01	20.01	0	0	0	1	1463	1	Alive	1463	No	No	1463	19	yes	yes	yes	None	19	yes	None	yes	None	pair_T.BC	
CCRC-0020	2	Hepatic Flexure	20	70	None	None	male	58	T3N0M0	II	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	1.65	4.05	0	0	0	1	1581	1	Alive	1581	No	No	1581	20	yes	yes	yes	None	20	yes	None	yes	None	pair_T.BC	
CCRC-0021	2	Asending Colon	5	90	None	None	male	83	T3N0M0	II	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	2.68	4.6	0	0	0	None	1445	1	Alive	1445	No	No	1445	21	yes	yes	yes	None	21	yes	None	yes	None	pair_T.BC	
CCRC-0022	1	Sigmoid Colon	5	90	None	None	male	70	T3N0M0	II	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	6.65	2	0	0	0	None	1291	1	Alive	1291	No	No	1291	22	yes	yes	yes	None	22	yes	None	yes	None	pair_T.BC	
CCRC-0023	3	Rectum	15	80	None	None	female	54	T3N0M0	II	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	2.94	7.34	0	0	0	None	1407	1	Alive	1407	No	No	1407	23	yes	yes	yes	None	23	yes	None	yes	None	pair_T.BC	
CCRC-0024	3	Rectum	20	75	None	None	male	79	T3N0M0	II	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	2.95	41.45	0	0	0	1	1519	1	Alive	1519	No	No	1519	24	yes	yes	yes	None	24	yes	None	yes	None	pair_T.BC	
CCRC-0025	3	Rectum	25	70	None	None	female	60	T3N0M0	II	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	3.87	17.19	0	None	None	0.66	1596	1	Alive	1596	No	No	1596	25	yes	yes	yes	None	25	yes	None	yes	None	pair_T.BC	
CCRC-0026	2	Hepatic Flexure	20	60	None	None	male	58	T4bN0M0	II	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	2.32	41.62	None	None	None	0.5	1649	1	Alive	1649	No	No	1649	26	yes	yes	yes	None	26	yes	None	yes	None	pair_T.BC	
CCRC-0028	1	Sigmoid Colon	20	60	None	None	male	67	T4aN1cM0	III	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	2.51	10.15	1	1	0	None	1438	1	Alive	1438	Yes(liver)	Yes	954	28	yes	yes	yes	None	28	yes	None	yes	None	pair_T.BC	
CCRC-0030	1	Sigmoid Colon	10	80	None	None	female	63	T3N0M1	IV	M(PreoperativeTreatment)	liver	Yes;with targeted agents	FOLFOX+Cetuximab	TRG1	None	Moderately differentiated adenocarcinoma	11.53	38.49	0	0	0	0.25	1212	1	Alive	1212	Yes(rectum;lung)	Yes	901	30	yes	yes	yes	yes	30	yes	yes	yes	None	pair_T.BC	
CCRC-0033	1	Sigmoid Colon	10	80	None	None	female	61	T3N1M1	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma	7.13	16.73	0	0	0	1	720	2	Death	720	Yes(widespread)	Yes	720	33	yes	yes	yes	yes	33	yes	yes	yes	None	pair_T.BC	
CCRC-0034	1	Sigmoid Colon	10	80	None	None	male	69	T3N0M1	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma	2.4	17.79	0	0	0	None	1249	1	Alive	1249	No	No	1249	34	yes	yes	yes	yes	34	yes	Fail in QC of D sample	yes	None	pair_T.BC	
CCRC-0035	3	Rectum	5	85	None	None	female	68	T3N1bM1a	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma	58.4	<2	1	0	0	None	1123	1	Alive	1123	Yes(Primary esophageal cancer)	Yes	1065	35	yes	yes	yes	yes	35	yes	yes	yes	None	pair_T.BC	
CCRC-0038	2	Asending Colon	5	90	None	None	female	54	T3N2bM1	IV	M	liver,peritoneum,mesentery	No	None	None	None	Poorly differentiated adenocarcinoma	2.04	>1200	1	1	0	None	None	2	Death	None	Yes(relapse)	Yes	None	38	yes	yes	yes	yes	38	yes	yes	yes	None	pair_T.BC	
CCRC-0039	3	Rectum	10	70	None	None	female	65	T3N1bM1	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma	None	8.88	0	0	0	None	1210	1	Alive	1210	No	No	1210	39	yes	yes	yes	None	39	yes	None	yes	None	pair_T.BC	
CCRC-0040	2	Transverse	15	70	None	None	male	53	T3N0M1	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma	196.98	391.51	1	0	0	1	929	2	Death	929	Yes(widespread)	Yes	929	40	yes	yes	yes	None	40	yes	None	yes	None	pair_T.BC	
CCRC-0041	2	Hepatic Flexure	5	50	20	40	male	55	T3N0M1	IV	M(PreoperativeTreatment)	liver	Yes	None	None	None	Moderately differentiated adenocarcinoma	15.4	55.3	0	0	0	1	949	1	Alive	949	No	No	949	41	yes	yes	yes	yes	41	yes	Fail in QC of D sample	None	yes	pair_T.N	
CCRC-0043	2	Asending Colon	10	80	70	20	female	63	T4bN2aM1	IV	M(PreoperativeTreatment)	liver	Yes	None	None	CAPEOX+Cetuximab;+Bevacizumab	Moderately differentiated adenocarcinoma	4.06	16.35	0	0	0	0.8	893	1	Alive	893	No	No	893	43	yes	yes	yes	yes	43	yes	yes	yes	None	pair_T.BC	
CCRC-0044	3	Rectosigmoid Junction	5	85	None	None	male	58	T3N1bM1a	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma	7.29	6.26	0	0	0	0.66	895	1	Alive	895	Yes(lymph gland)	Yes	775	44	yes	yes	yes	yes	44	yes	yes	yes	None	pair_T.BC	
CCRC-0045	3	Rectum	5	85	None	None	male	68	T3N1aM1	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma	1.45	2	0	0	0	1	932	1	Alive	932	No	No	932	45	yes	yes	yes	yes	45	yes	Fail in QC of D sample	yes	None	pair_T.BC	
CCRC-0046	2	Cecum	10	70	None	None	female	50	T2N0M1	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma	13.7	88.6	0	0	0	0.5	950	1	Alive	950	Yes(liver;lung)	Yes	435	46	yes	yes	yes	yes	46	yes	yes	None	yes	pair_T.N	
CCRC-0048	1	Splenic Flexure	25	60	None	None	male	64	T3N1M0	III	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	2.66	9.95	0	1	None	1	1649	1	Alive	1649	Yes(Primary lymphoid tumor)	Yes	1317	48	yes	yes	yes	None	48	yes	None	yes	None	pair_T.BC	
CCRC-0049	3	Rectum	10	80	None	None	female	70	T1N0M0	I	noM(PreoperativeTreatment)	None	Yes	None	None	None	Moderately differentiated adenocarcinoma	2.4	8.92	0	0	0	0.5	1650	1	Alive	1650	No	No	1650	49	yes	yes	yes	None	49	yes	None	yes	None	pair_T.BC	
CCRC-0050	3	Rectum	5	85	None	None	female	60	T1N0M0	I	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	0.74	7.69	0	None	None	0.5	1591	1	Alive	1591	No	No	1591	50	yes	yes	yes	None	50	yes	None	yes	None	pair_T.BC	
CCRC-0053	3	Rectum	10	70	None	None	male	68	T3N0M0	II	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	7.77	110.92	0	0	0	None	1186	2	Death	1186	Yes	Yes	1186	53	yes	yes	yes	None	53	yes	None	yes	None	pair_T.BC	
CCRC-0055	1	Sigmoid Colon	10	80	None	None	male	57	T3N0M1	IV	M	bladder	No	None	None	None	Moderately differentiated adenocarcinoma	2	13.1	0	0	0	0.75	1371	1	Alive	1371	No	No	1371	55	yes	yes	yes	None	55	yes	None	yes	None	pair_T.BC	
CCRC-0057	3	Rectum	5	85	None	None	male	62	T3N2M0	III	noM	None	No	None	None	CAPEOX+Bevacizumab	Moderately differentiated adenocarcinoma	9.8	310.48	0	None	None	1	1476	2	Death	1476	Yes(lung)	Yes	807	57	yes	yes	yes	None	57	yes	None	yes	None	pair_T.BC	
CCRC-0058	3	Rectum	10	80	None	None	female	50	T3N0M0	II	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	20.9	21.21	0	0	1	0.33	1526	1	Alive	1526	No	No	1526	58	yes	yes	yes	None	58	yes	None	yes	None	pair_T.BC	
CCRC-0059	3	Rectum	10	80	None	None	male	53	T4N2M0	III	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	2.91	3.34	None	None	None	1	1602	1	Alive	1602	Yes(liver)	Yes	1147	59	yes	yes	yes	None	59	yes	None	yes	None	pair_T.BC	
CCRC-0061	3	Rectum	5	90	None	None	male	62	T4N1M0	III	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	0.85	4.77	1	None	None	0.25	1612	1	Alive	1612	No	No	1612	61	yes	yes	yes	None	61	yes	None	None	yes	pair_T.N	
CCRC-0063	3	Rectum	10	80	None	None	male	71	T3N1M0	III	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	2.63	9.87	0	0	0	None	1553	1	Alive	1553	No	No	1553	63	yes	yes	yes	None	63	yes	None	yes	None	pair_T.BC	
CCRC-0064	3	Rectum	10	80	None	None	male	71	T3N2bM0	III	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	30.33	1.08	0	None	None	1	1587	1	Alive	1587	No	No	1587	64	yes	yes	yes	None	64	yes	None	yes	None	pair_T.BC	
CCRC-0065	1	Rectosigmoid Junction	10	80	None	None	male	70	T3N2aM0	III	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	2.76	13.79	0	None	None	0.5	1328	1	Alive	1328	No	No	1328	65	yes	yes	yes	None	65	yes	None	None	yes	pair_T.N	
CCRC-0066	1	Sigmoid Colon	15	70	None	None	female	58	T2N0M0	I	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	1.14	14.21	0	0	0	None	1375	1	Alive	1375	No	No	1375	66	yes	yes	yes	None	66	yes	None	yes	None	pair_T.BC	
CCRC-0067	3	Rectum	10	80	None	None	male	66	T2N0M0	I	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	3.6	3.66	0	0	0	0.33	1574	1	Alive	1574	No	No	1574	67	yes	yes	yes	None	67	yes	None	yes	None	pair_T.BC	
CCRC-0068	1	Sigmoid Colon	10	85	None	None	female	71	T2N0M0	I	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	1.89	12.2	0	0	0	None	1506	1	Alive	1506	No	No	1506	68	yes	yes	yes	None	68	yes	None	yes	None	pair_T.BC	
CCRC-0069	1	Sigmoid Colon	5	90	None	None	male	71	T1N0M0	I	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	2.99	16.95	0	0	0	None	1471	1	Alive	1471	No	No	1471	69	yes	yes	yes	None	69	yes	None	yes	None	pair_T.BC	
CCRC-0070	2	Asending Colon	5	90	None	None	male	74	T2N0M0	I	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	2.82	9.44	0	0	0	None	1410	1	Alive	1410	No	No	1410	70	yes	yes	yes	None	70	yes	None	yes	None	pair_T.BC	
CCRC-0071	3	Rectum	20	70	None	None	male	77	T2N0M0	I	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	1.65	7.81	0	0	0	0.8	1429	1	Alive	1429	No	No	1429	71	yes	yes	yes	None	71	yes	None	yes	None	pair_T.BC	
CCRC-0072	1	Sigmoid Colon	10	85	None	None	female	78	T1N0M0	I	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	4.68	<2	0	0	0	None	1499	1	Alive	1499	No	No	1499	72	yes	yes	yes	None	72	yes	None	yes	None	pair_T.BC	
CCRC-0076	3	Rectum	10	80	None	None	male	82	T3N0M0	II	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	3.85	5.21	0	None	None	None	1476	1	Alive	1476	No	No	1476	76	yes	yes	yes	None	76	yes	None	yes	None	pair_T.BC	
CCRC-0079	1	Splenic Flexure	30	60	None	None	female	67	T3N1M0	III	noM	None	No	None	None	CAPEOX+Cetuximab	Moderately differentiated adenocarcinoma	4.56	30.32	1	0	0	1	1442	1	Alive	1442	Yes(uterus)	Yes	323	79	yes	yes	yes	None	79	yes	None	yes	None	pair_T.BC	
CCRC-0082	3	Rectum	20	70	None	None	male	52	T2N0M0	I	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	1.06	8.05	0	None	None	0.25	1644	1	Alive	1644	No	No	1644	82	yes	yes	yes	None	82	yes	None	yes	None	pair_T.BC	
CCRC-0083	3	Rectum	20	60	None	None	male	62	T3N0M0	II	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	21.2	9.18	0	None	None	1	1610	1	Alive	1610	No	No	1610	83	yes	yes	yes	None	83	yes	None	yes	None	pair_T.BC	
CCRC-0084	3	Rectum	30	60	None	None	female	83	T3N0M0	II	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	1.74	6.57	0	None	None	0.66	1637	1	Alive	1637	No	No	1637	84	yes	yes	yes	None	84	yes	None	yes	None	pair_T.BC	
CCRC-0089	3	Rectum	10	80	None	None	male	66	T3N1bM0	III	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	3.79	4.71	0	None	None	None	1604	1	Alive	1604	Yes(Primary gastric cancer)	Yes	1338	89	yes	yes	yes	None	89	yes	None	yes	None	pair_T.BC	
CCRC-0090	2	Hepatic Flexure	20	70	None	None	male	70	T4aN0M0	II	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	4.85	7.09	0	0	0	None	1414	1	Alive	1414	No	No	1414	90	yes	yes	yes	None	90	yes	None	yes	None	pair_T.BC	
CCRC-0092	2	Hepatic Flexure	20	70	None	None	female	74	T3N1M0	III	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma; Mucinous adenocarcinoma	22.87	>1200	0	0	0	None	1579	1	Alive	1579	No	No	1579	92	yes	yes	yes	None	92	yes	None	yes	None	pair_T.BC	
CCRC-0093	3	Rectum	20	70	None	None	male	63	T3N0M0	II	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	15.26	<2	0	0	0	None	1442	1	Alive	1442	No	No	1442	93	yes	yes	yes	None	93	yes	None	None	yes	pair_T.N	
CCRC-0094	2	Hepatic Flexure	5	80	None	None	female	73	T3N1M0	III	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	6.18	23.59	0	None	None	0.75	1609	1	Alive	1609	No	No	1609	94	yes	yes	yes	None	94	yes	None	None	yes	pair_T.N	
CCRC-0095	3	Rectum	5	70	None	None	male	66	T3N0M0	II	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	8.48	15.8	0	None	None	0.5	1586	1	Alive	1586	Yes(lung,bone)	Yes	1467	95	yes	yes	yes	None	95	yes	None	yes	None	pair_T.BC	
CCRC-0096	3	Rectum	10	80	None	None	male	52	T3N0M0	II	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	5.96	5.94	0	0	0	None	1484	1	Alive	1484	No	No	1484	96	yes	yes	yes	None	96	yes	None	yes	None	pair_T.BC	
CCRC-0098	1	Sigmoid Colon	5	85	None	None	male	54	T2N0M0	I	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	6.23	15.29	0	0	0	None	1319	1	Alive	1319	No	No	1319	98	yes	yes	yes	None	98	yes	None	yes	None	pair_T.BC	
CCRC-0108	1	Sigmoid Colon	10	80	None	None	female	73	T3N1M0	III	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	7.94	13.47	0	0	0	0.66	1470	1	Alive	1470	No	No	1470	108	yes	yes	yes	None	108	yes	None	yes	None	pair_T.BC	
CCRC-0109	3	Rectum	15	70	None	None	female	69	T3N1M0	III	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	17.91	15.26	0	0	0	0.5	1489	1	Alive	1489	No	No	1489	109	yes	yes	yes	None	109	yes	None	yes	None	pair_T.BC	
CCRC-0112	2	Cecum	20	70	None	None	male	63	T4aN1M0	III	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	4.18	6.26	0	0	0	1	933	2	Death	933	Yes(widespread)	Yes	933	112	yes	yes	yes	None	112	yes	None	yes	None	pair_T.BC	
CCRC-0113	2	Transverse	5	85	None	None	female	51	T2N1bM0	III	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma; Mucinous adenocarcinoma	<0.5	14.12	0	0	0	0.66	1490	1	Alive	1490	No	No	1490	113	yes	yes	yes	None	113	yes	None	yes	None	pair_T.BC	
CCRC-0114	1;2	Asending Colon;Splenic Flexure	10	80	None	None	female	69	T4aN0M0	II	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma; Mucinous adenocarcinoma	1.53	13.11	1	0	1	None	1573	1	Alive	1573	No	No	1573	114	yes	yes	yes	None	114	yes	None	yes	None	pair_T.BC	
CCRC-0115	3	Rectum	20	60	None	None	male	62	T4N1M0	III	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	3.95	8.2	0	None	None	0.66	1592	1	Alive	1592	Yes(lung)	Yes	1322	115	yes	yes	yes	None	115	yes	None	yes	None	pair_T.BC	
CCRC-0116	3	Rectum	20	60	None	None	male	61	T3N0M1a	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma	2.7	4.9	0	0	0	1	992	1	Alive	992	No	No	992	116	yes	yes	yes	yes	116	yes	yes	yes	None	pair_T.BC	
CCRC-0117	3	Rectum	5	90	None	None	male	72	T3N2aM1b	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma; Mucinous adenocarcinoma	52.87	620.89	1	1	1	None	971	1	Alive	971	No	No	971	117	yes	yes	yes	yes	117	yes	yes	yes	None	pair_T.BC	
CCRC-0118	1	Sigmoid Colon	10	80	35	60	female	55	T3N2aM1a	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma; Mucinous adenocarcinoma	2.98	76.24	1	0	1	None	726	1	Alive	726	Yes(liver)	Yes	486	118	yes	yes	yes	yes	118	yes	yes	None	yes	pair_T.N	
CCRC-0119	2	Asending Colon	10	70	70	25	male	54	T3N1bM1	IV	M	liver	No	None	None	CAPEOX+Bevacizumab	Moderately differentiated adenocarcinoma	17.24	8.69	1	0	0	None	759	1	Alive	759	Yes(liver)	Yes	397	119	yes	yes	yes	None	119	yes	None	yes	None	pair_T.BC	
CCRC-0120	2	Asending Colon	5	90	None	None	female	64	T3N0M1	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma	0.8	38	0	0	1	None	1218	1	Alive	1218	No	No	1218	120	yes	yes	yes	None	120	yes	None	yes	None	pair_T.BC	
CCRC-0121	1	Sigmoid Colon	10	80	None	None	male	68	T3N0M1	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma	203.05	239.46	0	0	0	1	522	2	Death	522	Yes(widespread)	Yes	522	121	yes	yes	yes	None	121	yes	None	yes	None	pair_T.BC	
CCRC-0122	2	Hepatic Flexure	10	80	None	None	female	53	T3N1bM1	IV	M	liver	No	None	None	CAPEOX+Bevacizumab	Moderately differentiated adenocarcinoma; Mucinous adenocarcinoma	24.07	445.59	1	0	0	None	1253	2	Death	1253	Yes(pelvic cavity)	Yes	468	122	yes	yes	yes	yes	122	yes	yes	yes	None	pair_T.BC	
CCRC-0123	1	Sigmoid Colon	10	80	None	None	male	71	T3N1aM1	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma	20.9	234	0	0	0	None	9	2	Death	9	Yes(widespread)	Yes	9	123	yes	yes	yes	None	123	yes	None	yes	None	pair_T.BC	
CCRC-0125	2	Asending Colon	20	70	None	None	female	67	T4N2M1	IV	M	liver	No	None	None	None	Poorly differentiated adenocarcinoma; Mucinous adenocarcinoma	798.04	9.64	0	1	0	1	335	2	Death	335	Yes(widespread)	Yes	335	125	yes	yes	yes	None	125	yes	None	yes	None	pair_T.BC	
CCRC-0126	3	Rectum	10	80	None	None	male	65	T3N1bM1	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma	61.72	7.43	1	0	0	0.5	1282	1	Alive	1282	Yes(liver)	Yes	190	126	yes	yes	yes	None	126	yes	None	yes	None	pair_T.BC	
CCRC-0127	2	Asending Colon	5	85	None	None	male	73	T2N2bM1	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma	27.75	>1200	1	1	1	1	477	2	Death	477	Yes(widespread)	Yes	477	127	yes	yes	yes	None	127	yes	None	yes	None	pair_T.BC	
CCRC-0128	3	Rectum	5	90	None	None	male	60	T2N1cM1	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma	7.12	86.81	1	1	0	None	295	2	Death	295	Yes(widespread)	Yes	295	128	yes	yes	yes	None	128	yes	None	yes	None	pair_T.BC	
CCRC-0129	3	Rectum	10	80	None	None	male	67	T3N1cM1	IV	M(PreoperativeTreatment)	liver	Yes	None	None	CAPEOX+Cetuximab	Moderately differentiated adenocarcinoma	7.6	27.21	1	0	0	0.66	736	2	Death	736	Yes	Yes	736	129	yes	yes	yes	None	129	yes	None	yes	None	pair_T.BC	
CCRC-0130	3	Rectum	15	70	None	None	male	53	T3N2M1	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma	0.94	12.1	1	0	0	1	1484	1	Alive	1484	No	No	1484	130	yes	yes	yes	None	130	yes	None	yes	None	pair_T.BC	
CCRC-0131	3	Rectum	10	80	None	None	female	75	T3N2bM1	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma	95.07	93.74	0	1	0	None	401	2	Death	401	Yes(widespread)	Yes	401	131	yes	yes	yes	None	131	yes	None	yes	None	pair_T.BC	
CCRC-0132	3	Rectum	15	75	None	None	male	60	T2N1bM1	IV	M(PreoperativeTreatment)	liver,lung	Yes;with targeted agents	CAPEOX+Bevacizumab	TRG3	None	Moderately differentiated adenocarcinoma	145.34	1169.17	1	0	0	None	None	2	Death	None	Yes(widespread)	Yes	None	132	yes	yes	yes	None	132	yes	None	yes	None	pair_T.BC	
CCRC-0133	1	Desending Colon	10	80	50	40	female	60	T3N0M1	IV	M(PreoperativeTreatment)	liver	Yes	None	None	None	Moderately differentiated adenocarcinoma	1.31	155.45	1	1	0	1	None	2	Death	None	Yes	Yes	None	133	yes	yes	yes	None	133	yes	None	yes	None	pair_T.BC	
CCRC-0135	3	Rectosigmoid Junction	15	75	None	None	male	65	T3N0M1	IV	M(PreoperativeTreatment)	liver	Yes;with targeted agents	FOLFOX+Bevacizumab	TRG1	CAPEOX+Bevacizumab;+Cetuximab	Moderately differentiated adenocarcinoma	16.6	<2	0	0	0	0.66	985	1	Alive	985	No	No	985	135	yes	yes	yes	None	135	yes	None	yes	None	pair_T.BC	
CCRC-0136	3	Rectum	20	60	None	None	male	62	T3N0M1	IV	M(PreoperativeTreatment)	liver	Yes;with targeted agents	CAPEOX+Bevacizumab	TRG3	None	Moderately differentiated adenocarcinoma	102.35	148.92	0	0	1	None	396	2	Death	396	Yes(widespread)	Yes	396	136	yes	yes	yes	None	136	yes	None	yes	None	pair_T.BC	
CCRC-0139	2	Hepatic Flexure	5	90	60	20	male	62	T3N0M1	IV	M(PreoperativeTreatment)	liver	Yes;with targeted agents	CAPEOX+Bevacizumab	TRG3	None	Moderately differentiated adenocarcinoma	1.9	13.5	0	0	0	None	1105	1	Alive	1105	No	No	1105	139	yes	yes	yes	None	139	yes	None	yes	None	pair_T.BC	
CCRC-0141	3	Rectum	10	80	60	30	female	69	T3N1M1	IV	M(PreoperativeTreatment)	liver	Yes;with targeted agents	CAPEOX+Cetuximab	TRG3	None	Moderately differentiated adenocarcinoma	6.78	6.25	0	0	0	None	528	2	Death	528	Yes(widespread)	Yes	528	141	yes	yes	yes	yes	141	yes	yes	yes	None	pair_T.BC	
CCRC-0142	3	Rectum	2	80	1	90	male	53	T3N1bM1	IV	M(PreoperativeTreatment)	liver	Yes;with targeted agents	CAPEOX+Cetuximab	TRG3	None	Poorly differentiated adenocarcinoma	1.88	15.33	0	0	0	0.66	129	2	Death	129	Yes(widespread)	Yes	129	142	yes	yes	yes	None	142	yes	None	yes	None	pair_T.BC	
CCRC-0145	1	Sigmoid Colon	5	90	None	None	male	60	T3N1aM1	IV	M(PreoperativeTreatment)	liver	Yes	None	None	None	Moderately differentiated adenocarcinoma	40.41	5.41	0	0	1	None	489	2	Death	489	Yes(widespread)	Yes	489	145	yes	yes	yes	None	145	yes	None	yes	None	pair_T.BC	
CCRC-0146	1	Splenic Flexure	10	60	60	25	male	76	T3N2M1	IV	M(PreoperativeTreatment)	liver	Yes	None	None	None	Moderately differentiated adenocarcinoma	9.96	0.6	0	0	0	0.33	258	2	Death	258	Yes(widespread)	Yes	258	146	yes	yes	yes	yes	146	yes	yes	None	yes	pair_T.N	
CCRC-0147	3	Rectum	10	80	None	None	male	69	T3N0M1	IV	M(PreoperativeTreatment)	liver	Yes	None	None	None	Moderately differentiated adenocarcinoma	2.89	9.09	0	0	0	0.6	1359	1	Alive	1359	No	No	1359	147	yes	yes	yes	None	147	yes	None	None	yes	pair_T.N	
CCRC-0150	2	Asending Colon	25	65	None	None	male	63	T3N0M1	IV	M(PreoperativeTreatment)	liver	Yes	None	None	None	Moderately differentiated adenocarcinoma	4.36	407.39	0	0	0	1	253	2	Death	253	Yes(widespread)	Yes	253	150	yes	yes	yes	None	150	yes	None	yes	None	pair_T.BC	
CCRC-0151	3	Rectum	10	85	None	None	male	57	T3N0M1	IV	M(PreoperativeTreatment)	liver	Yes	None	None	None	Moderately differentiated adenocarcinoma	0.9	2.9	0	0	0	None	1251	2	Death	1251	Yes(liver)	Yes	354	151	yes	yes	yes	None	151	yes	None	yes	None	pair_T.BC	
CCRC-0204	1	Sigmoid Colon	5	90	20	45	male	68	T1bN1aM1	IV	M(PreoperativeTreatment)	liver	Yes;with targeted agents	CAPEOX; FOLFOX+Cetuximab	TRG1	None	Moderately differentiated adenocarcinoma	43.57	47.88	0	0	0	None	561	1	Alive	561	Yes(liver)	Yes	410	204	yes	yes	yes	yes	204	yes	yes	yes	None	pair_T.BC	
CCRC-0205	3	Rectum	10	70	15	70	male	53	T3N0M1	IV	M	liver	No	None	None	FOLFOX+Cetuximab	Moderately differentiated adenocarcinoma	None	None	None	None	None	None	561	1	Alive	561	Yes(liver)	Yes	93	205	yes	yes	yes	yes	205	yes	None	yes	None	pair_T.BC	
CCRC-0207	1	Desending Colon	10	80	25	60	male	66	T4N1M1	IV	M(PreoperativeTreatment)	liver	Yes;with targeted agents	CAPEOX+Cetuximab	TRG3	CAPEOX+Cetuximab	Moderately differentiated adenocarcinoma	2.74	3.79	0	0	0	None	507	1	Alive	507	Yes(liver)	Yes	354	207	yes	yes	yes	yes	207	yes	yes	None	yes	pair_T.N	
CCRC-0208	2	Asending Colon	10	85	80	15	male	56	T3N2M1	IV	M(PreoperativeTreatment)	liver	Yes;with targeted agents	CAPEOX+Bevacizumab	TRG3	None	Moderately differentiated adenocarcinoma	118.61	48.96	1	1	1	None	None	3	Loss	None	Loss	None	None	208	yes	yes	yes	yes	208	yes	yes	None	yes	pair_T.N	
CCRC-0211	3	Rectum	15	65	80	15	female	71	T4aN2aM1	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma	16.72	<2.0	1	1	1	0.5	441	1	Alive	441	Yes(lung)	Yes	355	211	yes	yes	yes	yes	211	yes	yes	yes	None	pair_T.BC	
CCRC-0212	3	Rectosigmoid Junction	5	90	15	70	male	51	T3N1bM1	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma	15.53	15.93	0	0	0	1	420	1	Alive	420	Yes(liver)	Yes	239	212	yes	yes	yes	yes	212	yes	yes	yes	None	pair_T.BC	
CCRC-0213	3	Rectum	5	85	None	None	male	71	T3N0M0	II	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	1.35	2.78	0	0	0	1	419	1	Alive	419	No	No	419	213	yes	yes	yes	None	213	yes	None	yes	None	pair_T.BC	
CCRC-0214	1	Sigmoid Colon	5	80	None	None	male	52	T2N0M0	I	noM	None	No	None	None	None	Mucinous adenocarcinoma	1.64	7.76	0	0	0	None	419	1	Alive	419	No	No	419	214	yes	yes	yes	None	214	yes	None	yes	None	pair_T.BC	
CCRC-0215	3	Rectum	30	65	None	None	male	70	T3N1bM0	III	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	6.7	8.15	0	0	0	1	418	1	Alive	418	Yes(liver)	Yes	209	215	yes	yes	yes	None	215	yes	None	yes	None	pair_T.BC	
CCRC-0217	3	Rectum	5	60	None	None	male	64	T2N0M0	I	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma; Mucinous adenocarcinoma	0.99	2.17	0	0	0	0.33	413	1	Alive	413	No	No	413	217	yes	yes	yes	None	217	yes	None	yes	None	pair_T.BC	
CCRC-0218	3	Rectum	5	90	None	None	female	79	TisN0M0	0	noM	None	No	None	None	None	High-grade intraepithelial neoplasia, carcinoma in situ, partial adenocarcinoma	2.06	6	0	0	0	0.5	415	1	Alive	415	No	No	415	218	yes	yes	yes	None	218	yes	None	None	yes	pair_T.N	
CCRC-0219	3	Rectum	10	75	None	None	male	73	T3N1aM1	IV	M	lung	No	None	None	None	Moderately differentiated adenocarcinoma	5.94	28.75	1	0	0	0.75	413	1	Alive	413	Yes(lung)	Yes	383	219	yes	yes	yes	None	219	yes	None	yes	None	pair_T.BC	
CCRC-0220	2	Cecum	20	65	None	None	male	67	T3N1bM0	III	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	2.45	5	0	0	1	0.5	411	1	Alive	411	No	No	411	220	yes	yes	yes	None	220	yes	None	yes	None	pair_T.BC	
CCRC-0221	1	Sigmoid Colon	10	80	None	None	female	68	T3N0M0	II	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	None	None	0	0	0	0.66	441	1	Alive	=Y113	No	No	=Y113	221	yes	yes	yes	None	221	yes	None	yes	None	pair_T.BC	
CCRC-0222	3	Rectum	10	75	None	None	male	76	T3N2aM1	IV	M	lung	No	None	None	None	Moderately differentiated adenocarcinoma	8.99	17.23	0	1	0	1	412	1	Alive	412	No	No	412	222	yes	yes	yes	yes	222	yes	None	yes	None	pair_T.BC	
CCRC-0223	3	Rectum	10	80	None	None	female	64	T3N2bM0	III	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	3.98	11.96	1	1	1	1	412	1	Alive	412	Yes(abdomil cavity)	Yes	261	223	yes	yes	yes	None	223	yes	None	yes	None	pair_T.BC	
CCRC-0225	1	Sigmoid Colon	10	85	None	None	male	77	T3N0M0	II	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	5.96	8.6	0	0	0	1	404	1	Alive	404	No	No	404	225	yes	yes	yes	None	225	yes	None	None	yes	pair_T.N	
CCRC-0226	2	Hepatic Flexure	10	80	None	None	male	81	T3N0M0	II	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	1.91	6.86	0	0	0	None	434	1	Alive	=Y117	No	No	=Y117	226	yes	yes	yes	None	226	yes	None	None	yes	pair_T.N	
CCRC-0228	2	Asending Colon	15	75	None	None	male	62	T3N0M0	II	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	4.9	9.29	0	0	0	0.5	404	1	Alive	404	No	No	404	228	yes	yes	yes	None	228	yes	None	yes	None	pair_T.BC	
CCRC-0230	2	Hepatic Flexure	15	65	None	None	male	55	T3N1bM0	III	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma; Mucinous adenocarcinoma	None	None	0	0	0	1	404	1	Alive	404	No	No	404	230	yes	yes	yes	None	230	yes	None	yes	None	pair_T.BC	
CCRC-0232	3	Rectum	15	75	None	None	male	52	T2N0M0	I	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	4.5	13.4	0	0	0	None	398	1	Alive	398	No	No	398	232	yes	yes	yes	None	232	yes	None	yes	None	pair_T.BC	
CCRC-0233	3	Rectum	10	80	None	None	female	57	T2N1bM0	III	noM(PreoperativeTreatment)	None	Yes	None	None	None	Moderately differentiated adenocarcinoma	3.8	8.5	0	0	0	None	404	1	Alive	404	No	No	404	233	yes	yes	yes	None	233	yes	None	yes	None	pair_T.BC	
CCRC-0235	2	Asending Colon	10	85	None	None	female	64	T2N1aM0	III	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	4.93	12.55	0	0	0	0.5	397	1	Alive	397	No	No	397	235	yes	yes	yes	None	235	yes	None	None	yes	pair_T.N	
CCRC-0237	2	Asending Colon	5	60	None	None	male	67	T4aN1M0	III	noM	None	No	None	None	None	Poorly-moderately differentiated adenocarcinoma	76.46	8.96	0	0	1	1	35	2	Death	35	Yes	Yes	35	237	yes	yes	yes	None	237	yes	None	yes	None	pair_T.BC	
CCRC-0238	3	Rectum	10	80	None	None	female	72	T3N1aM0	III	noM	None	No	None	None	None	Poorly-moderately differentiated adenocarcinoma	5.61	19.53	0	0	0	0.75	391	1	Alive	391	No	No	391	238	yes	yes	yes	None	238	yes	None	yes	None	pair_T.BC	
CCRC-0239	2	Hepatic Flexure	10	80	None	None	male	53	T1N0M0	I	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	1.74	6.52	0	0	0	0.75	398	1	Alive	398	No	No	398	239	yes	yes	yes	None	239	yes	None	yes	None	pair_T.BC	
CCRC-0240	1	Splenic Flexure	15	70	None	None	male	71	T4aN0M0	II	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma; Mucinous adenocarcinoma	2.34	3.05	0	0	0	None	400	1	Alive	400	No	No	400	240	yes	yes	yes	None	240	yes	None	yes	None	pair_T.BC	
CCRC-0242	1	Sigmoid Colon	5	55	None	None	female	57	T4N1M0	III	noM	None	No	None	None	None	Poorly-moderately differentiated adenocarcinoma	6.97	86.24	1	0	0	1	401	1	Alive	401	No	No	401	242	yes	yes	yes	None	242	yes	None	yes	None	pair_T.BC	
CCRC-0243	1	Splenic Flexure	20	75	None	None	male	67	T4aN2bM1	IV	M	enterocoelia	No	None	None	None	Poorly-moderately differentiated adenocarcinoma	6.24	>1200	1	1	0	1	127	2	Death	127	Yes	Yes	127	243	yes	yes	yes	None	243	yes	None	yes	None	pair_T.BC	
CCRC-0244	3	Rectum	5	90	None	None	male	72	T3N0M0	II	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	2.71	6.29	0	0	0	0.66	390	1	Alive	390	No	No	390	244	yes	yes	yes	None	244	yes	None	yes	None	pair_T.BC	
CCRC-0246	3	Rectum	20	60	None	None	female	76	T3N0M0	II	noM	None	No	None	None	None	Poorly differentiated adenocarcinoma; Mucinous adenocarcinoma	None	None	0	0	0	0.66	398	1	Alive	398	No	No	398	246	yes	yes	yes	None	246	yes	None	None	yes	pair_T.N	
CCRC-0247	1	Splenic Flexure	15	80	None	None	female	67	T3N1bM1	IV	M(PreoperativeTreatment)	liver	Yes;with targeted agents	CAPEOX+Cetuximab	TRG3	CAPEOX+Cetuximab	Moderately differentiated adenocarcinoma	7.27	28.49	0	0	1	1	388	1	Alive	388	Yes(lung)	Yes	242	247	yes	yes	yes	yes	247	yes	yes	yes	None	pair_T.BC	
CCRC-0248	3	Rectum	10	50	None	None	male	61	T3N1M1	IV	M(PreoperativeTreatment)	liver	Yes;with targeted agents	CAPEOX+Bevacizumab	TRG3	None	Moderately differentiated adenocarcinoma; Mucinous adenocarcinoma	10.5	55.6	0	0	0	0.66	384	1	Alive	384	No	No	384	248	yes	yes	yes	yes	248	yes	yes	yes	None	pair_T.BC	
CCRC-0249	1	Sigmoid Colon	10	85	None	None	male	51	T2N0M1	IV	M(PreoperativeTreatment)	liver	Yes	None	None	None	Moderately differentiated adenocarcinoma	138.65	<2	0	0	0	0.5	381	1	Alive	381	No	No	381	249	yes	yes	yes	yes	249	yes	yes	None	yes	pair_T.N	
CCRC-0250	1	Sigmoid Colon	10	80	80	15	male	55	T3N1bM1	IV	M(PreoperativeTreatment)	liver	Yes;with targeted agents	CAPEOX+Bevacizumab	TRG3	CAPEOX+Bevacizumab	Moderately differentiated adenocarcinoma	21.97	12.56	1	0	0	0.66	355	1	Alive	355	No	No	355	250	yes	yes	yes	yes	250	yes	yes	yes	None	pair_T.BC	
CCRC-0251	3	Rectum	10	80	25	70	female	64	T4N1M1	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma	81.3	1139.64	1	1	1	1	148	2	Death	148	Yes(widespread)	Yes	148	251	yes	yes	yes	yes	251	yes	yes	yes	None	pair_T.BC	
CCRC-0252	3	Rectum	20	70	None	None	male	71	T3N1aM0	III	noM	None	No	None	None	None	Moderately differentiated adenocarcinoma	27.53	13.06	0	0	0	0.75	367	1	Alive	367	No	No	367	252	yes	yes	yes	None	252	yes	None	yes	None	pair_T.BC	
CCRC-0253	3	Rectum	20	70	None	None	male	60	T3N0M0	II	noM(PreoperativeTreatment)	None	Yes	None	None	None	Moderately differentiated adenocarcinoma	2.75	12.16	0	0	0	0.66	1178	1	Alive	1178	No	No	1178	253	yes	yes	yes	None	253	yes	None	yes	None	pair_T.BC	
CCRC-0255	3	Rectum	20	70	30	65	male	59	T3N2bM1	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma	4.38	2.52	1	0	0	1	385	1	Alive	=Y138	No	No	=Y138	255	yes	yes	yes	yes	255	yes	yes	yes	None	pair_T.BC	
CCRC-0256	2	Hepatic Flexure	10	85	None	None	male	79	T3N2aM1	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma	>1500	>1200	0	1	1	1	None	3	Loss	None	Loss	None	None	256	yes	yes	yes	None	256	yes	None	yes	None	pair_T.BC	
CCRC-0257	2	Asending Colon	20	70	70	25	female	73	T4aN1M1	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma; Mucinous adenocarcinoma	8.94	65.13	1	1	0	0.66	269	2	Death	269	Yes(widespread)	Yes	269	257	yes	yes	yes	yes	257	yes	yes	yes	None	pair_T.BC	
CCRC-0259	3	Rectosigmoid Junction	15	80	40	50	male	62	T3N1aM1	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma	27.92	273.55	0	0	0	0.66	314	1	Alive	314	No	No	314	259	yes	yes	yes	yes	259	yes	yes	yes	None	pair_T.BC	
CCRC-0265	2	Asending Colon	10	75	10	60	male	70	T3N0M1	IV	M	liver	No	None	None	None	Moderately differentiated adenocarcinoma	68.86	9.08	0	0	0	0.5	319	1	Alive	319	Yes(liver)	Yes	226	265	yes	yes	yes	yes	265	yes	yes	yes	None	pair_T.BC	
CCRC-0323	2	Cecum	20	70	60	30	male	74	T3N1M1	IV	M;miniPDX done	liver	No	None	None	None	Moderately differentiated adenocarcinoma	1.23	160.37	1	1	1	1	190	1	Alive	190	Yes(liver)	Yes	68	323	yes	yes	yes	yes	323	yes	yes	yes	None	pair_T.BC	
CCRC-0381	3	Rectum	10	80	60	20	male	64	T3N0M1	IV	M(PreoperativeTreatment);miniPDX done	liver	Yes	None	None	None	Moderately differentiated adenocarcinoma	1.93	<2	0	0	0	0.25	52	1	Alive	52	No	No	52	381	yes	yes	yes	yes	381	yes	yes	None	yes	pair_T.N	
CCRC-0382	2	Asending Colon	15	80	50	30	male	70	T3N1M1	IV	M(PreoperativeTreatment);miniPDX done	liver	Yes;with targeted agents	CAPEOX+Bevacizumab	TRG3	None	Moderately differentiated adenocarcinoma	9.57	15.68	0	0	0	0.5	52	1	Alive	52	No	No	52	382	yes	yes	yes	yes	382	yes	yes	yes	None	pair_T.BC	
CCRC-0397	3	Rectum	10	80	60	30	male	53	T3N2M1	IV	M;miniPDX done	liver	No	None	None	None	Poorly-moderately differentiated adenocarcinoma	1.93	2.84	1	1	1	1	31	1	Alive	31	No	No	31	397	yes	yes	yes	yes	397	yes	yes	yes	None	pair_T.BC	
CCRC-0398	1	Sigmoid Colon	40	50	45	40	female	55	T3N1M1	IV	M;miniPDX done	liver	No	None	None	None	Poorly-moderately differentiated adenocarcinoma; Mucinous adenocarcinoma	276.52	>1200	1	1	0	1	27	1	Alive	27	No	No	27	398	yes	yes	yes	yes	398	yes	yes	yes	None	pair_T.BC	
